Featured publications
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
November 2, 2023 | The New England Journal of Medicine
Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development
April 5, 2023 | Frontiers in Molecular Biosciences
Quantifying the nativeness of antibody sequences using long short-term memory networks
December 31, 2019 | Protein Engineering, Design, and Selection
Antibody-Based Strategies to Prevent and Treat Influenza.
July 13, 2015 | Frontiers in Immunology
Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.
April 11, 2015 | Current Opinion in Virology
Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.
June 20, 2013 | Cell
Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.
June 6, 2013 | Cell
Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.
May 22, 2013 | Virus Research
Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.
April 23, 2013 | PLoS One
Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.
April 23, 2013 | PLoS One
Modular glycosphere assays for high-throughput functional characterization of influenza viruses.
April 15, 2013 | BMC Biotechnology
Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.
April 8, 2013 | Proceedings of the National Academy of Sciences of the United States of America
Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin.
February 20, 2013 | PloS One
